北京时间2024年12月18日01时40分，Amneal Pharmaceuticals, Inc.（AMRX.us）股票出现波动，股价快速拉升5.03%。截至发稿，该股报8.14美元/股，成交量47.5977万股，换手率0.15%，振幅5.10%。

最近的财报数据显示，该股实现营业收入7.02亿美元，净利润-156000.00美元，每股收益0.00美元，毛利2.70亿美元，市盈率-9.46倍。

机构评级方面，在所有4家参与评级的机构中，75%的券商给予买入建议，25%的券商给予持有建议，无券商给予卖出建议。

Amneal Pharmaceuticals, Inc.股票所在的制药行业中，整体涨幅为0.50%。其相关个股中，Petros Pharmaceuticals, Inc.、梯瓦制药、Procaps Group S.A. C/Wts 29/09/2026 (To Pur Com)涨幅较大，Petros Pharmaceuticals, Inc.、Cbdmd, Inc.、Painreform Ltd.较为活跃，换手率分别为130.66%、19.86%、12.46%，振幅较大的相关个股有Petros Pharmaceuticals, Inc.、Scilex Holding Company C/Wts 10/11/2027 (To Pur Com)、Medicus Pharma Ltd.，振幅分别为38.13%、25.00%、24.57%。

海量资讯、精准解读，尽在新浪财经APP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.